Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
…thematous (SLE). We report a case of recurrent ALP treated with anifrolumab.Methods A 47-year-old man presented in August 2022 with progres…
… refractory to multiple therapies, highlighting the response to rituximab. Prior reports support the benefit of rituximab in SLE-associat…
…tologic (lymphopenia), and serologic activity (SLEDAI-2K 6–8 on prednisolone 10 mg/day).Results In August 2024, anifrolumab 300 mg IV monthl…
…nosed with SLE, while one patient developed uveitis while under azathioprine treatment. Therapeutic management included local corticosteroid…
…ar necrosis of both femoral heads. Current medications included mycophenolate mofetil, methylprednisolone, nifedipine, bosentan, and aspirin, along w…
…ntric Castleman disease was done, and interleukin 6 antagonist, siltuximab, was given every 4 weeks. Subsequently, the patient developed h…
…regimen was intravenous Methylprednisolone pulses combined with Mycophenolate Mofetil. Partial remission was achieved in 100% of patients (2.7 months…
…Objectives Methylprednisolone (mPSL) pulse therapy is an essential treatment for systemic lup…
…ely associated with remission in model 2. Higher daily baseline prednisone dose was negatively associated with sustained remission in mode…
…ter long-term prognosis is expected. Methylprednisolone pulses (MP) have the potential to initiate rapid and mighty anti-inflammat…
…N after exclusion of other causes. The infant was discharged on aspirin (3 mg/kg/day) and antihypertensives and remains well on follow-…
…udies exist, but CSIs containing 10 mg of methylprednisolone or triamcinolone per facet joint and 40 mg per sacroiliac joint (SIJ) (or their …